Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Dorairaj Prabhakaran

General Cardiology

View

Dr. Pugazhendhi Vijayaraman

EP · Geisinger

View

Dr. Robert Schaller

EP · HUP

View

Dr. Trey Woods

General Cardiology · Emory Healthcare

View

Dr. Brahmajee Nallamothu

Interventional Cardiology · UMHS

View

Dr. Felix Yang

EP · NYU Langone

View

Dr. Jennifer Rymer

Interventional & Peripheral Cards · Duke University

View

Dr. Ami Bhatt

Adult Congenital Heart Disease · MGH

View

Dr. Gregory Marcus

EP · UCSF

View

Dr. Connor O'Brien

Cardiac Critical Care · UCSF Medical Center

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Radial Access Approach to Peripheral Vascular Interventions: A Scientific Statement From the American Heart Association.

    Dec 4, 2024DOI: 10.1161/hcv.0000000000000094Journal ArticleAHA

    Written by: Jason C KovacicKimberly A SkeldingShipra AryaJennifer Ballard-HernandezMayank GoyalNkechinyere N IjiomaKimberly KicielinskiEdwin A TakahashiFrancisco UjuetaGeorge DangasAmerican Heart Association Cardiovascular Interventions Science Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Peripheral Vascular Disease; and Council on Cardiovascular Radiology and Intervention

    Find these authors on Roon

    FU
    Dr. Francisco Ujueta
    Vascular Medicine · VUMC

    Summary

    Transradial arterial access has transformed the field of coronary interventions, where it has several advantages over femoral access, such as reduced bleeding and access site complications, improved patient comfort, shorter time to ambulation after the procedure, reduced length of hospital stay, and potentially reduced mortality rates. Because of these benefits, as well as the concurrent expanding indications for various endovascular therapies, there is growing interest in adopting radial access for peripheral vascular interventions. However, radial access can present challenges, and specialized equipment for peripheral interventions through this route are under development. Nevertheless, a growing number of studies, largely comprising single-center and registry data, have broadly suggested that transradial arterial access is likely to be safe and associated with reduced bleeding and local access site complications for most peripheral interventions compared with transfemoral access. Large, prospective randomized trials are lacking, and the question of any effect on mortality rates has not been addressed. Whereas the field of transradial arterial access for peripheral vascular interventions is in development, it is clear that this approach, at least with available equipment, will not be suitable for all patients, and careful case selection is paramount. Furthermore, the remaining knowledge gaps must be addressed, and robust outcome data obtained, to allow full understanding of the factors that determine optimal patient, lesion, and equipment selection. Nevertheless, the use of transradial arterial access for peripheral vascular interventions holds great promise, particularly if the necessary technologic advances are rapid and favorable clinical trial data continue to emerge.
    FUDr. Francisco Ujueta

    Dr. Francisco Ujueta

    Cardiology · Vascular Medicine
    Vanderbilt University Medical Center
    franciscou
    Nashville, TN, USA